These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29986213)

  • 21. Advances of small molecule targeting of kinases.
    Berndt N; Karim RM; Schönbrunn E
    Curr Opin Chem Biol; 2017 Aug; 39():126-132. PubMed ID: 28732278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cryo-EM for Small Molecules Discovery, Design, Understanding, and Application.
    Scapin G; Potter CS; Carragher B
    Cell Chem Biol; 2018 Nov; 25(11):1318-1325. PubMed ID: 30100349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of small-molecule structures to complement protein-ligand crystal structures in drug discovery.
    Groom CR; Cole JC
    Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):240-245. PubMed ID: 28291759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applications of the NRGsuite and the Molecular Docking Software FlexAID in Computational Drug Discovery and Design.
    Morency LP; Gaudreault F; Najmanovich R
    Methods Mol Biol; 2018; 1762():367-388. PubMed ID: 29594781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computation of binding energies including their enthalpy and entropy components for protein-ligand complexes using support vector machines.
    Koppisetty CA; Frank M; Kemp GJ; Nyholm PG
    J Chem Inf Model; 2013 Oct; 53(10):2559-70. PubMed ID: 24050538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Covalent fragment-based drug discovery for target tractability.
    McCarthy WJ; van der Zouwen AJ; Bush JT; Rittinger K
    Curr Opin Struct Biol; 2024 Jun; 86():102809. PubMed ID: 38554479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-target residence time--a case for G protein-coupled receptors.
    Guo D; Hillger JM; IJzerman AP; Heitman LH
    Med Res Rev; 2014 Jul; 34(4):856-92. PubMed ID: 24549504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative proteomics of kinase inhibitor targets and mechanisms.
    Daub H
    ACS Chem Biol; 2015 Jan; 10(1):201-12. PubMed ID: 25474541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel approaches to map small molecule-target interactions.
    Kapoor S; Waldmann H; Ziegler S
    Bioorg Med Chem; 2016 Aug; 24(15):3232-45. PubMed ID: 27240466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular fields in ligand discovery.
    Gane PJ; Chan AW
    Methods Mol Biol; 2013; 1008():479-99. PubMed ID: 23729264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Recognition of Unrelated Ligands by Identical Proteins.
    Pottel J; Levit A; Korczynska M; Fischer M; Shoichet BK
    ACS Chem Biol; 2018 Sep; 13(9):2522-2533. PubMed ID: 30095890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMR in structure-based drug design.
    Carneiro MG; Ab E; Theisgen S; Siegal G
    Essays Biochem; 2017 Nov; 61(5):485-493. PubMed ID: 29118095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The design and application of target-focused compound libraries.
    Harris CJ; Hill RD; Sheppard DW; Slater MJ; Stouten PF
    Comb Chem High Throughput Screen; 2011 Jul; 14(6):521-31. PubMed ID: 21521154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Critical Review of Validation, Blind Testing, and Real- World Use of Alchemical Protein-Ligand Binding Free Energy Calculations.
    Abel R; Wang L; Mobley DL; Friesner RA
    Curr Top Med Chem; 2017; 17(23):2577-2585. PubMed ID: 28413950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling and Deorphanization of Orphan GPCRs.
    Diaz C; Angelloz-Nicoud P; Pihan E
    Methods Mol Biol; 2018; 1705():413-429. PubMed ID: 29188576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structures of G protein-coupled receptors reveal new opportunities for drug discovery.
    Cooke RM; Brown AJ; Marshall FH; Mason JS
    Drug Discov Today; 2015 Nov; 20(11):1355-64. PubMed ID: 26303408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic Use of GPCR Modeling and SDM Experiments to Understand Ligand Binding.
    Potterton A; Heifetz A; Townsend-Nicholson A
    Methods Mol Biol; 2018; 1705():335-343. PubMed ID: 29188570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thermodynamic profiling for fragment-based lead discovery and optimization.
    Ferenczy GG; Keserű GM
    Expert Opin Drug Discov; 2020 Jan; 15(1):117-129. PubMed ID: 31741402
    [No Abstract]   [Full Text] [Related]  

  • 39. Modelling and enhanced molecular dynamics to steer structure-based drug discovery.
    Kalyaanamoorthy S; Chen YP
    Prog Biophys Mol Biol; 2014 May; 114(3):123-36. PubMed ID: 23827463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational Methods Used in Hit-to-Lead and Lead Optimization Stages of Structure-Based Drug Discovery.
    Heifetz A; Southey M; Morao I; Townsend-Nicholson A; Bodkin MJ
    Methods Mol Biol; 2018; 1705():375-394. PubMed ID: 29188574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.